Physician profile
Steven Blake
NPI 1831555010
$8,984.10
in general payments reported to CMS, 2019-2025
14 companies · $281 in 2025
The $281 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,664 · 2020: $1,399 · 2021: $2,232 · 2022: $1,511 · 2023: $1,589 · 2024: $308 · 2025: $281.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,125 · Food and Beverage: $1,011 · Entertainment: $23.01 · Consulting Fee: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,125.00 |
| Food and Beverage | $1,010.62 |
| Entertainment | $23.01 |
| Consulting Fee | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $4,553.92 | 2019-2025 | Misight Contact Lens, Myday Contact Lens |
| Alcon Vision LLC | $2,282.77 | 2019-2025 | Precision7, Precision 1, Total30 |
| Johnson & Johnson Vision Care, INC. | $1,054.91 | 2019-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $276.61 | 2019-2021 | |
| Allergan, INC. | $251.41 | 2019 | |
| Bausch & Lomb Americas INC. | $147.58 | 2022-2025 | Infuse |
| Glaukos Corporation | $108.65 | 2021 | |
| Johnson & Johnson Surgical Vision, INC. | $100.83 | 2020-2024 | Lipiflow System Activator (Disposable) |
| Carl Zeiss Meditec, INC. | $71.12 | 2019 | |
| Biotissue Holdings INC. | $53.81 | 2024 | |
| Abbvie INC. | $23.16 | 2025 | |
| Optos, INC. | $23.01 | 2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Spark Therapeutics, INC. | $20.91 | 2022 | |
| Maculogix, INC. | $15.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Blake listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.